References
- LENFANT C: Task force on research in epidemiology andprevention of cardiovascular diseases. Circulation (1994) 90:2609–2617.
- BRAUNWALD E: ACE inhibitors - A cornerstone of thetreatment of heart failure. New Engl. J. Med. (1991) 325:351–353.
- SMITH R, TIMMERMANS PBMWM: Inhibition of the renin angiotensin system in congestive heart failure. Current Drugs (1992):A-127-A–150.
- PFEFFER MA, PFEFFER JM, STEINBERG CR, FINN P: Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopriL Circulation (1985) 72:406–412.
- SWEET CS, LUDDEN CT, STABILITO II, EMMERT SE, HEYSE JF: Beneficial effects of milrinone and enalapril on long-term survival of rats with healed myocardial in-farction. Eur. J. Pharmacol. (1988) 147:29–37.
- PACKER M, CARVER JR, RODEHEFFER RJ, IVANHOE RJ, DIBIANCO R, ZELDIS SM, HEN'DRIX GH, BOMMER WJ, ELKAYAM U, KUKIN ML, MALLIS GI, SOLLANO JA, SHAN-NON J, TANDON PK, DEMETS DL: Effect of oral milrinone on mortality in severe chronic heart failure. New Engl. J. Med. (1991) 325:1468–1475.